Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor

ClinicalTrials.gov ID: NCT01851070

Public ClinicalTrials.gov record NCT01851070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 7:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor

Study identification

NCT ID
NCT01851070
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mesoblast, Ltd.
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

  • Allogeneic Mesenchymal Precursor Cells Drug
  • Normal Saline Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2013
Primary completion
Apr 30, 2016
Completion
Feb 28, 2017
Last update posted
Jun 25, 2020

2013 – 2017

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
Arthrocare Arthritis Care and Research PC Gilbert Arizona 85234
Triwest Research Associates El Cajon California 92020
UCLA Los Angeles California 90025
Inland Rheumatology Clinical Trials Incorporated Upland California 91786
Ocala Rheumatology Research Center Ocala Florida 34474
Arthritis Center Palm Harbor Florida 34684
Sarasota Arthritis Research Center Sarasota Florida 34239
McIlwain Medical Group Tampa Florida 33614
JHU Arthritis Center Baltimore Baltimore Maryland 21224
Arthritis Treatment Center Frederick Maryland 21702
Reliant Medical Group Worcester Massachusetts 01605
Mayo Clinic Rochester Minnesota 55905
Office of Ramesh C. Gupta, MD Fair Lawn New Jersey 07410
DJL Clinical Research Charlotte North Carolina 28210
Health Research of Oklahoma Oklahoma City Oklahoma 73102
University of Pittsburgh Pittsburgh Pennsylvania 15261
West Tennessee Research Institute Jackson Tennessee 38305
Accurate Clinical Research Houston Texas 77034
Texas Arthritis Research Center San Antonio Texas 78217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01851070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01851070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →